Mai Abd El Meguid | Virology | Best Researcher Award

Published on by Sciencefather

Assoc. Prof. Dr. Mai Abd El Meguid | Virology | Best Researcher Award

Assoc. Prof. Dr. Mai Abd El Meguid | Virology | Associated Professor at National Research Centre | Egypt

Assoc. Prof. Dr. Mai Abd El Meguid is a distinguished molecular biologist at the National Research Centre, recognized for her outstanding contributions to liver disease, viral hepatitis, and cancer genetics research. She earned her Ph.D. in Molecular Biology from a leading university and has since developed an extensive professional experience portfolio, including leading multiple national and international research projects. Her research interests focus on hepatic fibrosis, hepatitis C virus pathogenesis, cytomegalovirus reactivation, and the impact of direct-acting antivirals on liver function, with an emphasis on translational applications that inform clinical interventions. Dr. Mai Abd El Meguid possesses strong research skills in molecular biology techniques, bioinformatics, gene expression analysis, and clinical data interpretation, enabling her to design and execute high-impact studies with precision. Her academic leadership is demonstrated through mentoring graduate students, guiding research teams, and contributing to professional organizations and volunteer platforms. She has an impressive publication record, with over 320 citations, an h-index of 10, and numerous contributions to high-impact journals such as Journal of Interferon & Cytokine Research, Genes & Diseases, and The American Journal of the Medical Sciences. Dr. Mai Abd El Meguid has received multiple awards and honors recognizing her research excellence, including acknowledgment from professional societies and academic institutions for her innovative contributions to liver disease research and public health impact. Her work has significantly advanced understanding of molecular mechanisms underlying liver fibrosis and viral hepatitis, as well as provided insights into personalized medical approaches for patients with chronic hepatitis C. With a combination of research expertise, leadership experience, and a record of scholarly excellence, Dr. Mai Abd El Meguid demonstrates remarkable potential for future contributions to biomedical research, particularly in enhancing Q1 journal publications, expanding global collaborations, and participating in international keynote lectures. Her career trajectory reflects a consistent commitment to scientific rigor, mentorship, and translating research outcomes into societal benefit. In conclusion, Dr. Mai Abd El Meguid is a highly deserving candidate for research awards and recognitions due to her significant scientific contributions, leadership in the field, and potential to drive impactful, globally relevant research in molecular biology and liver disease for years to come.

Academic Profile: ORCID | Scopus | Google Scholar

Featured Publications:

  1. Dawood, R. M., El-Meguid, M. A., Salum, G. M., & El Awady, M. K. (2020). Key players of hepatic fibrosis. Journal of Interferon & Cytokine Research, 40(10), 472–489. Cited by 66

  2. Dawood, R. M., Salum, G. M., El-Meguid, M. A. (2022). The impact of COVID-19 on liver injury. The American Journal of the Medical Sciences, 363(2), 94–103. Cited by 62

  3. Salum, G. M., Dawood, R. M., El-Meguid, M. A., Ibrahim, N. E., Aziz, A. O. A., … (2020). Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients. Genes & Diseases, 7(3), 392–400. Cited by 32

  4. Bader El Din, N. G., El-Meguid, M. A., Tabll, A. A., Anany, M. A., Esmat, G., … (2011). Human cytomegalovirus infection inhibits response of chronic hepatitis‐C‐virus‐infected patients to interferon‐based therapy. Journal of Gastroenterology and Hepatology, 26(1), 55–62. Cited by 32